← ANALYSTS · TIPRANKS
Annabel Samimy · Stifel Nicolaus
Hits
51%
232 of 459 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+19.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
15
Buy / hold / sell: 14 / 1 / 0
Upside of the analyst’s targets
+299.0%
Average over 13 current targets, to the last price
The market’s answer to the ratings
+4.9%
Day-0 move against SPY in the rating’s direction, average over 4 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 12on TipRanks 07:20 | MBXIWMMBX Biosciences, Inc. · $2.4B | Reiterated | Buy | $70.00 → $84.00+20.0% | +69.3% | −2.2%next day −5.8% | ↗ |
| Sep 28on TipRanks 06:55 | OCSOculis Holding · $486M | Reiterated | Buy | $40.00 | +448.7% | −1.5%next day +1.0% · 5 days −6.7% | ↗ |
| Sep 25on TipRanks 07:30 | RGNXIWMRegenXBio · $473M | Reiterated | Buy | $42.00 | +506.5% | +1.7%next day +1.7% · 5 days +0.6% | ↗ |
| Sep 23on TipRanks 06:50 | IVAInventiva · $877M | Reiterated | Buy | $15.00 | +410.2% | −4.8%next day −5.4% · 5 days +7.6% | ↗ |
| Sep 22on TipRanks Sep 23 06:05 | VKTXViking Therapeutics · $3.4B | Reiterated | Buy | $30.00 → $95.00+216.7% | +277.4% | +35.7%next day +2.7% · 5 days −20.9% | ↗ |
| Sep 22on TipRanks Sep 23 06:05 | LGNDIWMLigand Pharma · $6.0B | Reiterated | Buy | — | — | +2.9%next day +0.7% · 5 days +5.2% | ↗ |
| Aug 11on TipRanks Aug 12 22:05 | MBXIWMMBX Biosciences, Inc. · $2.4B | Reiterated | Buy | $70.00 | +41.1% | +0.1%next day +1.2% · 5 days +1.2% | ↗ |
| Aug 7on TipRanks 08:15 | TRVIIWMTrevi Therapeutics · $1.7B | Reiterated | Buy | $30.00 | +152.5% | −0.6%next day −3.8% · 5 days −0.7% | ↗ |
| Aug 6on TipRanks 07:56 | EOLSIWMEvolus · $500M | Reiterated | Buy | $17.00 | +139.4% | +20.1%next day +1.8% · 5 days +7.0% | ↗ |
| Aug 4on TipRanks 07:56 | JAZZJazz Pharmaceuticals · $13.9B | Reiterated | Buy | $230 → $275+19.6% | +30.8% | +2.2%next day +0.2% · 5 days −5.1% | ↗ |
| Jul 16on TipRanks Jul 15 16:20 | EYPTIWMEyePoint Pharmaceuticals · $271M | Initiated | Buy | $40.00 | +1,237.8% | −5.3%next day +3.0% · 5 days −2.7% | ↗ |
| Jun 24on TipRanks 06:50 | PVLAIWMPalvella Therapeutics · $1.8B | Reiterated | Buy | $250 | +107.8% | +9.4%next day +4.8% · 5 days +4.8% | ↗ |
| May 7on TipRanks 09:45 | MLYSIWMMineralys Therapeutics, Inc. · $1.9B | Reiterated | Buy | $52.00 | +156.2% | −2.2%next day −0.2% · 5 days −9.4% | ↗ |
| May 6on TipRanks 11:35 | SUPNIWMSupernus Pharmaceuticals · $2.3B | Reiterated | Hold | $55.00 | +45.2% | +3.2%next day +1.9% · 5 days −1.3% | ↗ |
| Jan 15on TipRanks 06:50 | PHATIWMPhathom Pharmaceuticals · $607M | Reiterated | Buy | $28.00 | +304.6% | −1.3%next day −6.1% · 5 days −9.4% | ↗ |
| Dec 19on TipRanks Dec 21 20:25 | ALTIWMAltimmune · $459M | Reiterated | Buy | — | — | −23.7%next day +5.5% · 5 days −6.7% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗